Cargando…

The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation

AIM OF THE STUDY: Aim of the study was to assess the impact of the recipient and donor interferon lambda-3 (IFNL3) single-nucleotide polymorphisms (SNPs) rs12979860 and rs8099917 on the course of hepatitis C virus (HCV) reinfection following liver transplantation. MATERIAL AND METHODS: The study inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieczorek-Godlewska, Renata, Płoski, Rafał, Perkowska-Ptasińska, Agnieszka, Tronina, Olga, Sadowska, Anna, Pacholczyk, Marek, Lisik, Wojciech, Durlik, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649482/ https://www.ncbi.nlm.nih.gov/pubmed/29062905 http://dx.doi.org/10.5114/ceh.2017.68401

Ejemplares similares

Negative Correlation Between Hepatitis C Virus (HCV) and Let-7 MicroRNA Family in Transplanted Livers: The Role of rs868 Single-Nucleotide Polymorphism
por: Sajjad, Emir Ahmed, et al.
Publicado: (2017)

Liver Transplantation for a Metastatic Pancreatic Solid-Pseudopapillary Tumor (Frantz Tumor): A Case Report
por: Wójciak, Michał, et al.
Publicado: (2018)

Pregnancy after liver transplant: maternal and perinatal outcomes
por: Marzec, Izabela, et al.
Publicado: (2021)

Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
por: Czarnecka, Paulina, et al.
Publicado: (2022)

Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients
por: Gniewkiewicz, Michal S., et al.
Publicado: (2020)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2018)

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV
por: Laidlaw, Stephen M., et al.
Publicado: (2014)

Are We on the Right Track for HCV Micro-Elimination? HCV Management Practices in Dialysis Centers in Poland—A National Cross-Sectional Survey
por: Czarnecka, Paulina, et al.
Publicado: (2023)

Potential utility of urinary chemokine CCL2 to creatinine ratio in prognosis of 5‐year graft failure and mortality post 1‐year protocol biopsy in kidney transplant recipients
por: Gniewkiewicz, Michal, et al.
Publicado: (2023)

Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (−) Negative in the Serum
por: Sikorska-Wiśniewska, Małgorzata, et al.
Publicado: (2021)

Diffusion Weighted Magnetic Resonance Imaging in the Assessment of Renal Function and Parenchymal Changes in Chronic Kidney Disease: A Preliminary Study
por: Sułkowska, Katarzyna, et al.
Publicado: (2020)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Genetic Variability of Hepatitis C Virus (HCV) 5’ Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin
por: Bukowska-Ośko, Iwona, et al.
Publicado: (2015)

The Comparison of the Podocyte Expression of Synaptopodin, CR1 and Neprilysin in Human Glomerulonephritis: Could the Expression of CR1 be Clinically Relevant?
por: Kubiak-Wlekły, Anna, et al.
Publicado: (2009)

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
por: Hamming, Ole J, et al.
Publicado: (2013)

The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C
por: Bellanti, F., et al.
Publicado: (2012)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
por: Steinbrink, Julie M., et al.
Publicado: (2023)

Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients
por: Alves, Camila Fernanda da Silveira, et al.
Publicado: (2016)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Genetics of the Human Interferon Lambda Region
por: Prokunina-Olsson, Ludmila
Publicado: (2019)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients
por: Ferri, Flaminia, et al.
Publicado: (2019)

Ambulatory Blood Pressure Monitoring as a Useful Tool in the Cardiological Assessment of Pancreas Transplant Recipients with Type 1 Diabetes
por: Buksińska-Lisik, Małgorzata, et al.
Publicado: (2023)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Usefulness of Pancreas Donor Risk Index and Pre-Procurement Pancreas Allocation Suitability Score: Results of the Polish National Study
por: Śmigielska, Kaja, et al.
Publicado: (2018)

Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
por: Chen, Ruoyang, et al.
Publicado: (2021)

Lambda Interferons: New Cytokines with Old Functions
por: Hamming, Ole J., et al.
Publicado: (2010)

Interferon Lambda: Modulating Immunity in Infectious Diseases
por: Syedbasha, Mohammedyaseen, et al.
Publicado: (2017)

Macrophage Coordination of the Interferon Lambda Immune Response
por: Read, Scott A., et al.
Publicado: (2019)

Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases
por: Wallace, Jonathan W., et al.
Publicado: (2021)

Interferon lambda in inflammation and autoimmune rheumatic diseases
por: Goel, Rishi R., et al.
Publicado: (2021)

Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience
por: Czarnecka, Kinga, et al.
Publicado: (2022)

Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study
por: Eckman, Mark H., et al.
Publicado: (2021)

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
por: Straś, Wojciech Andrzej, et al.
Publicado: (2022)

Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy
por: Flisiak, Robert, et al.
Publicado: (2021)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dgj2pap3hn78eqc9s94213654m